Ju&Mi Junczyk I Miszkurka sp. j.
Overview
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 82 days for 2021).
- 202515/07/2026
- 202429/06/2025
- 202315/07/2024
- 202206/07/2023
- 202105/10/2022
- 202018/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Ownership
| Owner |
|---|
Robert Junczyk age 48 |
Tomasz Miszkurka age 51 |
Manner of representation
Each partner has the right to represent the company. Each partner is authorised to make declarations of will concerning property and non-property rights and obligations and to sign on behalf of the company, as well as to receive declarations of will on behalf of the company, independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-08-21.
61 1020 1127 0000 1802 0238 3065
43 1020 1127 0000 1902 0255 8716
48 1020 1127 0000 1402 0270 5341
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $121,235.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,822$2,822 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,822$2,822 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,167$3,167 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitama S.A. | $4,287,087.38 | vitama.pl | ||
| Natur Day S.A. | $680,635.59 | naturday.pl | ||
| Biotrio sp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voice sp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Poland sp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar Pharma S.A. | $85,649.72 | munar.pl | ||
| Bioresearch Pharma S.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotech sp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefea sp. z o.o. | $294.66 | cefea.pl | ||
| Grupa Finepharm S.A. | – | finepharm.pl |
FAQ
Last updated: 2026-07-16